key: cord-0929024-zf1mng24
authors: Yahav, Dafna
title: COVID-19 in special populations
date: 2022-03-10
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2022.02.038
sha: 99a15db7ca7bbf69213294452910ed38283d6b00
doc_id: 929024
cord_uid: zf1mng24

nan

Since the onset of COVID-19 pandemic, we have learned that certain populations deserve different approach to various aspects of the pandemic. These aspects may include increased risk of exposure (e.g., people who live or work in congregate setting), higher risk of transmission (e.g., children), increased risk for severe disease and death (e.g., immunocompromised and elderly patients), lower availability of vaccines (e.g., people who live in low-medium income countries, migrant population), or lower immunogenicity in response to vaccines (e.g., immunocompromised and elderly population). Results of clinical trials evaluating therapies or preventive measures for COVID-19 are likely not applicable for these populations. (1) In this theme issue we aimed to provide a closer look on some of these populations -to define what are the challenges related to COVID-19 in each population, to present available data to address these challenges, suggest solutions, and highlight knowledge gaps related to the pandemic among specific populations. Choosing the populations to discuss in this issue, we tried to present populations with various trajectories of the pandemic. Experts in infectious diseases, microbiology and immunology, internal and family medicine, and community health sciences, participated in this issue. pandemic. The authors provide data on several aspects that deserve attention, in this population suffering from poor outcomes following COVID-19. First, they describe commonly reported atypical clinical presentation of COVID-19 in elderly, with higher rates of impaired consciousness, disorientation, and delirium compared to younger adults, and lower rates of typical symptoms, such as fever and shortness of breath. Attention to this atypical presentation is needed to avoid missed diagnosis. The authors overview short term mortality rates reported in the literature among elderly, ranging between 11%, but mostly ~40% to 77%. They suggest that frailty and comorbidities, rather than age itself, predict mortality, and hence the broad variability in mortality presented. Another explanation for the variability may be different criteria for acceptance to intensive care unit, with elderly excluded in some centers and in earlier stages of the pandemic. Reasons for increased mortality are suggested, including multiple comorbidities, impaired immune function due to ageing, delayed diagnosis attributed to atypical presentation, limited access to ICU, as well as 

Funding -no external funding

ESCMID Study Group for Infections in the Elderly (ESGIE). A systematic review assessing the under-representation of elderly adults in COVID-19 trials

Vaccines alone will not prevent COVID-19 outbreaks among migrant workers -the example of meat processing plants

Caring for older adults during the COVID-19 pandemic

An Overview of COVID-19 in Solid Organ Transplantation